Navigation Links
Exercise training in ordinary people affects the activity of 500 genes

A new study from Karolinska Institutet in Stockholm shows that hundreds of genes in the thigh muscle are activated in regular cycle training. The study also reveals that great differences in training response may be due to the ability in some people to activate their genes much more forcefully. The study is published May 2 in FASEB Journal.

It is common knowledge that it is very dangerous to be inactive and that regular physical activity brings health, improves quality of life and extends life span. How these positive effects are created in the body is not known. Influences on gene activity in the heart, vessels and muscles are probably immensely important.

In this study, the first of its kind, Drs James Timmons, Carl J Sundberg and co-workers show that hundreds of genes are activated by regular cycle training for six weeks in young healthy men. Some of these genes are most likely linked to diabetes and cardiovascular disease. These training study findings can therefore be important for the development of new treatment strategies for such diseases.

Some people respond more easily to training than others. It is not known what explains this. The results from the training study show that those individuals that improved their performance most also activated several genes in the muscles markedly more. This has not been shown before.

Finally, the researchers made a comparison between the effects of endurance training and the situation in patients with Duchenne's muscle dystrophy, a muscle wasting disease. Most of the muscle genes previously claimed to be specific for Duchenne were also activated with endurance training. Maybe the musculature in Duchenne patients strive to adapt in part similar to what happens in training. The results from this study will help to clarify which genes are uniquely affected in Duchenne.


Source:Karolinska Institutet

Page: 1

Related biology news :

1. Exercise aside, genes may ultimately dictate seniors mobility
2. Exercise pill switches on gene that tells cells to burn fat
3. Stem cell training program to make its Stanford debut
4. Laboratory professionals in Africa receive training under AIDS Relief Plan
5. Lance Armstrong through a physiological lens: hard training boosts muscle power 8%
6. Research finds music training tunes human auditory system
7. Extraordinary life found around deep-sea gas seeps
8. New insight into people who see colors in letters and numbers
9. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
10. Increased risk of osteoporosis associated with gene that one in five people have
11. Brain activity related to processing faces is similar in people with, without autism
Post Your Comments:

(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: